Insulet Corp. (PODD)
145.63
-2.53
(-1.71%)
USD |
NASDAQ |
Aug 24, 16:00
145.50
-0.13
(-0.09%)
After-Hours: 20:00
Insulet Shareholders Equity (Quarterly) : 1.422B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.422B |
| March 31, 2026 | 1.303B |
| December 31, 2025 | 1.515B |
| September 30, 2025 | 1.384B |
| June 30, 2025 | 1.463B |
| March 31, 2025 | 1.331B |
| December 31, 2024 | 1.212B |
| September 30, 2024 | 1.118B |
| June 30, 2024 | 998.40M |
| March 31, 2024 | 790.70M |
| December 31, 2023 | 732.70M |
| September 30, 2023 | 607.50M |
| June 30, 2023 | 553.90M |
| March 31, 2023 | 502.80M |
| December 31, 2022 | 476.40M |
| September 30, 2022 | 428.00M |
| June 30, 2022 | 422.40M |
| March 31, 2022 | 446.70M |
| December 31, 2021 | 556.30M |
| September 30, 2021 | 497.90M |
| June 30, 2021 | 459.10M |
| March 31, 2021 | 585.30M |
| December 31, 2020 | 603.60M |
| September 30, 2020 | 595.00M |
| June 30, 2020 | 563.30M |
| Date | Value |
|---|---|
| March 31, 2020 | 59.00M |
| December 31, 2019 | 75.90M |
| September 30, 2019 | 150.57M |
| June 30, 2019 | 249.78M |
| March 31, 2019 | 223.63M |
| December 31, 2018 | 212.10M |
| September 30, 2018 | 197.93M |
| June 30, 2018 | 179.15M |
| March 31, 2018 | 170.57M |
| December 31, 2017 | 158.52M |
| September 30, 2017 | 74.25M |
| June 30, 2017 | 64.72M |
| March 31, 2017 | 63.58M |
| December 31, 2016 | 63.15M |
| September 30, 2016 | 65.10M |
| June 30, 2016 | 27.44M |
| March 31, 2016 | 26.40M |
| December 31, 2015 | 34.05M |
| September 30, 2015 | 55.13M |
| June 30, 2015 | 70.26M |
| March 31, 2015 | 80.74M |
| December 31, 2014 | 83.83M |
| September 30, 2014 | 80.34M |
| June 30, 2014 | 77.88M |
| March 31, 2014 | 122.49M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| DexCom, Inc. | 2.621B |
| Boston Scientific Corp. | 24.93B |
| PROCEPT BioRobotics Corp. | 340.07M |
| Globus Medical, Inc. | 4.769B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.165B |
| Total Liabilities (Quarterly) | 1.743B |
| Debt to Equity Ratio | 0.6669 |
| Current Ratio | 2.448 |
| Net Debt Paydown Yield | 1.41% |